A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Local Institution - 0029, New York

Local Institution - 0015, Córdoba

Local Institution - 0002, Philadelphia

Local Institution - 0026, Nashville

Local Institution - 0001, San Antonio

Local Institution - 0008, Villejuif

Local Institution - 0006, Boston

Local Institution - 0021, Calgary

Local Institution - 0018, Barcelona